Hangzhou Phecdamed Co., Ltd.
Clinical trials sponsored by Hangzhou Phecdamed Co., Ltd., explained in plain language.
-
New drug TJ0113 tested in healthy people for first time
Knowledge-focused CompletedThis early-stage trial tested the safety and tolerability of TJ0113 capsules in 130 healthy adults. Participants received either single or multiple doses of the drug or a placebo, and some took it after a high-fat meal. The study measured side effects and how the drug moves throu…
Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Drug tracking study in healthy men completed
Knowledge-focused CompletedThis study looked at how a drug called TJ0113 is processed and removed from the body in healthy Chinese men. Six participants took a single dose, and researchers measured the drug in their blood, urine, and stool over time. The goal was to understand how the drug is eliminated, n…
Phase: PHASE1 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC